Profile data is unavailable for this security.
About the company
Cosmos Pharmaceutical Corp is a Japan-based company mainly engaged in the retail of pharmaceuticals and cosmetics. The Company’s products include pharmaceuticals such as over-the-counter medicines, energy drinks, oral care products, nursing care products, vitamins, health foods, diet foods, and prescriptions, cosmetics such as cosmetics, men's cosmetics, hair care products, and bath additives, miscellaneous goods such as baby products, detergents, insect repellents, air fresheners, bath and toilet supplies, cooking supplies, gardening supplies, car supplies, and clothing, general foods such as processed foods, daily necessities, seasonings, sweets, beverages, alcohol, and tobacco.
- Revenue in JPY (TTM)1.04tn
- Net income in JPY31.20bn
- Incorporated1983
- Employees5.71k
- LocationCosmos Pharmaceutical Corp4F, S Kan, Daiichi Fukuoka Bldg.2-10-1, Hakataeki HigashiHakata-kuFUKUOKA-SHI 812-0013JapanJPN
- Phone+81 924330660
- Websitehttps://www.cosmospc.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| H2O Retailing Corp | 682.74bn | 26.37bn | 301.92bn | 8.00k | 10.78 | 0.9125 | 5.64 | 0.4422 | 223.76 | 223.76 | 5,688.73 | 2,642.79 | 0.919 | 16.47 | 7.71 | 85,310,010.00 | 3.64 | 1.89 | 5.46 | 2.67 | 45.12 | 40.03 | 3.96 | 1.95 | 0.7356 | -- | 0.3445 | 30.12 | 3.71 | -5.35 | 59.06 | -- | -1.62 | 0.9806 |
| Kusuri No Aoki Holdings Co Ltd | 538.45bn | 18.80bn | 378.17bn | 5.63k | 21.21 | 2.83 | 11.38 | 0.7023 | 186.51 | 186.51 | 5,341.03 | 1,398.29 | 1.47 | 6.92 | 24.54 | 95,690,780.00 | 5.13 | 5.07 | 7.30 | 7.52 | 26.42 | 27.52 | 3.49 | 3.30 | 0.8297 | 49.09 | 0.5091 | 7.65 | 14.79 | 10.81 | 44.52 | 7.45 | 7.15 | 16.00 |
| Blue Zones Holdings Co Ltd | 787.06bn | 22.18bn | 401.43bn | 4.93k | 17.58 | 1.94 | 10.43 | 0.51 | 545.00 | 545.00 | 19,311.01 | 4,926.55 | 1.95 | 37.85 | 41.13 | 159,613,700.00 | 5.65 | 5.48 | 7.85 | 7.17 | 27.49 | 28.00 | 2.90 | 2.86 | 0.7475 | 43.67 | 0.2892 | 23.28 | 18.85 | 9.85 | 10.60 | 10.12 | 12.28 | 13.97 |
| Sundrug Co Ltd | 833.92bn | 31.15bn | 505.96bn | 7.15k | 15.92 | 1.78 | 10.21 | 0.6067 | 266.31 | 266.31 | 7,129.12 | 2,383.37 | 1.84 | 5.88 | 26.37 | 116,714,300.00 | 6.89 | 7.57 | 9.78 | 11.14 | 25.61 | 24.96 | 3.74 | 3.82 | 0.9192 | 41.15 | 0.1494 | 42.08 | 6.66 | 5.35 | 5.58 | 5.35 | 24.83 | 13.84 |
| Cosmos Pharmaceutical Corp | 1.04tn | 31.20bn | 548.73bn | 5.71k | 17.43 | 2.02 | 10.06 | 0.5263 | 393.63 | 393.63 | 13,154.99 | 3,395.66 | 2.03 | 8.50 | 1,396.69 | 182,629,000.00 | 6.06 | 6.40 | 10.63 | 11.71 | 21.11 | 20.23 | 2.99 | 3.02 | 0.2806 | 134.89 | 0.1297 | 15.59 | 4.81 | 8.12 | 26.68 | 7.64 | 15.50 | 20.55 |
| Sugi Holdings Co Ltd | 993.53bn | 42.30bn | 677.51bn | 11.82k | 15.26 | 2.30 | 10.87 | 0.6819 | 233.74 | 233.74 | 5,490.05 | 1,550.19 | 1.73 | 6.90 | 12.00 | 84,054,900.00 | 7.34 | 5.87 | 13.03 | 9.11 | 31.63 | 30.68 | 4.26 | 3.05 | 0.8575 | 17.46 | 0.2533 | 24.16 | 17.94 | 10.13 | 16.88 | 4.33 | 5.01 | 5.59 |
Data as of Mar 04 2026. Currency figures normalised to Cosmos Pharmaceutical Corp's reporting currency: Japanese Yen JPY
21.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 13 Feb 2026 | 6.12m | 7.65% |
| Nomura Asset Management Co., Ltd.as of 15 Dec 2025 | 4.60m | 5.76% |
| JPMorgan Asset Management (Japan) Ltd.as of 28 Nov 2025 | 1.42m | 1.78% |
| The Vanguard Group, Inc.as of 31 Jan 2026 | 1.36m | 1.70% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 988.55k | 1.24% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 553.20k | 0.69% |
| Amova Asset Management Co., Ltd.as of 06 Feb 2026 | 548.50k | 0.69% |
| JPMorgan Investment Management, Inc.as of 28 Nov 2025 | 538.60k | 0.67% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 532.40k | 0.67% |
| Fidelity Management & Research Co. LLCas of 30 Nov 2025 | 531.78k | 0.67% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
